{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:52:28Z","timestamp":1793764348417,"version":"4.6.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T00:00:00Z","timestamp":1561593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.euroneuro.2019.06.006","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T21:58:35Z","timestamp":1562882315000},"page":"905-913","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["A cross sectional study of impact and clinical risk factors of antipsychotic-induced OCD"],"prefix":"10.1016","volume":"29","author":[{"given":"Marjan","family":"Biria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona-Xiaofei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia","family":"Worbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi A.","family":"Fineberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor W.","family":"Robbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Fernandez-Egea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2019.06.006_bib0001","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/WNF.0000000000000248","article-title":"Early onset schizophrenia associated with obsessive-compulsive disorder: clinical features and correlates","volume":"40","author":"Baytunca","year":"2017","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0002","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1001\/jamapsychiatry.2016.2095","article-title":"Association of perinatal risk factors with obsessive-compulsive disorder: a population-based birth cohort, sibling control study","volume":"73","author":"Brander","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0003","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.comppsych.2016.04.009","article-title":"Well-being in clozapine-treated schizophrenia patients: the significance of positive symptoms","volume":"68","author":"Brown","year":"2016","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0004","first-page":"28","article-title":"The clinical global impressions scale: applying a research tool in clinical practice","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jad.2017.07.033","article-title":"Parental age and the risk of obsessive compulsive disorder and Tourette syndrome \/ chronic tic disorder in a nationwide population-based sample","volume":"223","author":"Chudal","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0006","doi-asserted-by":"crossref","first-page":"e768","DOI":"10.1038\/tp.2016.34","article-title":"Exon-focused genome-wide association study of obsessive-compulsive disorder and shared polygenic risk with schizophrenia","volume":"6","author":"Costas","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0007","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0376-8716(93)90010-N","article-title":"Cocaine use and other suspected risk factors for obsessive-compulsive disorder: a prospective study with data from the Epidemiologic Catchment Area surveys","volume":"31","author":"Crum","year":"1993","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0008","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1751-7893.2012.00377.x","article-title":"Presence of obsessive compulsive symptoms in first-episode schizophrenia or related disorders is associated with subjective well-being and quality of life","volume":"7","author":"De Haan","year":"2013","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0009","first-page":"1","article-title":"Distinct risk factors for obsessive and compulsive symptoms in chronic schizophrenia","author":"Fernandez-Egea","year":"2018","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0010","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ijnp\/pyx088","article-title":"Mapping compulsivity in the DSM-5 obsessive compulsive and related disorders: cognitive domains, neural circuitry, and treatment","volume":"21","author":"Fineberg","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0011","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1037\/1040-3590.14.4.485","article-title":"The Obsessive-Compulsive Inventory: development and validation of a short version","volume":"14","author":"Foa","year":"2002","journal-title":"Psychol. Assess."},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pnpbp.2007.06.024","article-title":"The analytical epidemiology of obsessive-compulsive disorder: risk factors and correlates","volume":"32","author":"Fontenelle","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0013","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1751-7893.2012.00357.x","article-title":"Markers of vulnerability to obsessive\u2013compulsive disorder in an ultra\u2010high risk sample of patients who developed psychosis","volume":"6","author":"Fontenelle","year":"2012","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0014","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.comppsych.2014.03.016","article-title":"Psychopathology and quality of life among patients with comorbidity between schizophrenia spectrum disorder and obsessive-compulsive disorder: no evidence for a \"schizo-obsessive\" subtype","volume":"55","author":"Frias","year":"2014","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0015","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1017\/S0033291711000894","article-title":"Risk factors prospectively associated with adult obsessive-compulsive symptom dimensions and obsessive-compulsive disorder","volume":"41","author":"Grisham","year":"2011","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0016","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1034\/j.1600-0447.107.s416.5.x","article-title":"The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia","author":"Haro","year":"2003","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0017","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.psychres.2015.01.021","article-title":"Associations of obsessive\u2013compulsive symptoms with clinical and neurocognitive features in schizophrenia according to stage of illness","volume":"226","author":"Kim","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0018","doi-asserted-by":"crossref","first-page":"542","DOI":"10.4088\/JCP.v68n0408","article-title":"De Novo Emergence of Obsessive-Compulsive Symptoms With Atypical Antipsychotics in Asian Patients With Schizophrenia or Schizoaffective Disorder","volume":"68","author":"Mahendran","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0019","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/mp.2014.43","article-title":"Genome-wide association study in obsessive-compulsive disorder: results from the OCGAS","volume":"20","author":"Mattheisen","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0020","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1001\/archpsyc.1984.01790170060007","article-title":"The chestnut lodge follow-up study: ii. long-term outcome of schizophrenia and the affective disorders","volume":"41","author":"McGlashan","year":"1984","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0021","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/0269881108089582","article-title":"Obsessive-compulsive disorder in UK clozapine-treated schizophrenia and schizoaffective disorder: a cause for clinical concern","volume":"23","author":"Mukhopadhaya","year":"2009","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0022","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0165-1781(01)00238-4","article-title":"Obsessive-compulsive disorder in hospitalized patients with chronic schizophrenia","volume":"102","author":"Poyurovsky","year":"2001","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0023","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ajmg.b.30148","article-title":"Familial aggregation of schizophrenia-spectrum disorders and obsessive-compulsive associated disorders in schizophrenia probands with and without OCD","volume":"133B","author":"Poyurovsky","year":"2005","journal-title":"Am. J. Med. Genet. Part B"},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0024","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.genhosppsych.2008.08.003","article-title":"Perinatal risk factors and obsessive-compulsive spectrum disorders in patients with rheumatic fever","volume":"31","author":"Sampaio","year":"2009","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0025","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1017\/S0033291711000419","article-title":"Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia","volume":"41","author":"Schirmbeck","year":"2011","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0026","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2174\/157015912799362724","article-title":"Clozapine-induced obsessive-compulsive symptoms in schizophrenia: a critical review","volume":"10","author":"Schirmbeck","year":"2012","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0027","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/schbul\/sbs123","article-title":"Stable cognitive deficits in schizophrenia patients with comorbid obsessive-compulsive symptoms: a 12-month longitudinal study","volume":"39","author":"Schirmbeck","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0028","first-page":"99","article-title":"Comorbid obsessive-compulsive symptoms in schizophrenia: contributions of pharmacological and genetic factors","volume":"4","author":"Schirmbeck","year":"2013","journal-title":"Front. Neuropharmacol."},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0029","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1503\/jpn.140021","article-title":"Increased orbitofrontal cortex activation association with \"pro-obsessive\" antipsychotic treatment in patients with schizoprehnia","volume":"40","author":"Schirmbeck","year":"2015","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0030","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1590\/0101-60830000000159","article-title":"The effect of obsessive compulsive symptoms on psychopathology in patients with schizophrenia","volume":"45","author":"Seng","year":"2018","journal-title":"Arch. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0031","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/da.22163","article-title":"Family aggregation and risk factors of obsessive-compulsive disorders in a nationwide three-generation study","volume":"30","author":"Steinhausen","year":"2013","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0032","article-title":"Longitudinal association between motor and obsessive compulsive symptoms in patients with psychosis and their unaffected siblings","author":"Swets","year":"2018","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci"},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0033","doi-asserted-by":"crossref","DOI":"10.3109\/13651501.2014.943243","article-title":"Obsessive compulsive symptoms are related to lower quality of life in patients with Schizophrenia","volume":"18","author":"\u00dc\u00e7ok","year":"2014","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0034","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jad.2008.01.025","article-title":"The association between parental bonding and obsessive compulsive disorder in offspring at high familial risk","volume":"111","author":"Wilcox","year":"2008","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2019.06.006_bib0035","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.psychres.2012.01.020","article-title":"Advanced paternal age increases the risk of schizophrenia and obsessive\u2013compulsive disorder in a chinese han population","volume":"198","author":"Wu","year":"2012","journal-title":"Psychiatry Res."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X19302640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X19302640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T18:31:10Z","timestamp":1663957870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X19302640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0924977X19302640"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2019.06.006","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A cross sectional study of impact and clinical risk factors of antipsychotic-induced OCD","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2019.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}